WO2002053065A1 - Radially expanding ureteral device - Google Patents

Radially expanding ureteral device Download PDF

Info

Publication number
WO2002053065A1
WO2002053065A1 PCT/US2001/024409 US0124409W WO02053065A1 WO 2002053065 A1 WO2002053065 A1 WO 2002053065A1 US 0124409 W US0124409 W US 0124409W WO 02053065 A1 WO02053065 A1 WO 02053065A1
Authority
WO
WIPO (PCT)
Prior art keywords
ureteral
elongate
cages
flexible
ureteral device
Prior art date
Application number
PCT/US2001/024409
Other languages
French (fr)
Inventor
Michael Edward Mitchell
Gloria Miran Ro
Aoy Tomita
Original Assignee
Fossa Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fossa Industries, Inc. filed Critical Fossa Industries, Inc.
Priority to EP01961878A priority Critical patent/EP1347716B1/en
Priority to DE60133834T priority patent/DE60133834T2/en
Priority to CA2431652A priority patent/CA2431652C/en
Publication of WO2002053065A1 publication Critical patent/WO2002053065A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/94Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/008Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0039H-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0058X-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0071Three-dimensional shapes spherical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0076Quadric-shaped ellipsoidal or ovoid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1078Urinary tract
    • A61M2210/1089Urethra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02Dilators made of swellable material

Definitions

  • the present invention relates to a medical device, and more particularly to a medical device for facilitating passage and/or removal of kidney stones.
  • Removal of stones from the kidneys or urinary tract can be effected medically or surgically.
  • a well known surgical approach involves passing a flexible basket in a retrograde manner up the ureter from the bladder, and using the basket to capture the stones.
  • Another surgical technique known as extracorporeal lithotripsy, entails transmission of high-intensity shock waves from outside the body to fragment the stones v thin the body. The resulting stone fragments are then voided with urine.
  • percutaneous ultrasonic lithotripsy requires the passage of a rigid cystoscopy-like instrument in the renal pelvis through a small incision in the flank whereupon stones are broken up by a small ultrasound transducer and removed directly.
  • Another surgical technique is laser lithotripsy via a ureteroscope. All of these procedures, which can be quite painful, are elaborate and expensive, and do not always result in complete removal of the stones and fragments.
  • Stents are used to decompress ureteral obstruction, ensuring that urine drains from the kidney to the bladder. It has also been recognized that placement of a stent within the ureter can help small stones and stone fragments to transit the ureter.
  • a guide wire is passed through the ureter to the renal pelvis.
  • a hollow, flexible, cylindrical stent is then advanced with a pusher over the guide wire.
  • the guide wire and pusher are then extracted from the stent and the body, leaving an open lumen for urine to pass through.
  • the lumen defined by the cylindrical stent is even smaller than the ureter itself, all but the smallest stones and sludge are precluded from passing therethrough. Some fragments are able to pass around the ureteral stent but larger stone fragments are unable to pass. In many cases, stone fragments often block the open stent passageway.
  • the present invention provides an improved ureteral device that is not only well- suited for decompressing an obstructed passage within the body such as a ureter, but which is also configured to gently dilate and thus facilitate stone passage through a ureter or duct.
  • a ureteral device in an exemplary embodiment, includes a flexible, elongate body that defines an open channel along the body. At least a portion of the body is made of a resilient material, wherein the open channel defines a void volume.
  • a retaining or compressive force applied to the resilient material causes the void volume to be reduced, or maintained in a reduced state, until the retaining or compressive force is removed or maintained in a reduced state, until the retaining or compressive force is removed.
  • a sleeve, a wire, or an adhesive soluble in liquid or dissolvable by ultrasound can provide the retaining force.
  • a flexible, elongate body includes elements distributed along the body and that are movable from a first state to a second state to increase the diameter of the ureteral device from a first diameter to a second diameter.
  • a flexible, elongate body defines a plurality of flexible elongate members which in turn define a plurality of cages.
  • the cages are movable from a cage contracted state to a cage expanded state.
  • FIGS. 1 is a perspective view of a ureteral device in accordance with the present invention
  • FIGS. 2 - 9D are detailed views of end portions of ureteral devices in accordance with present invention.
  • FIG. 10 illustrates the ureteral device of FIG. 3 compressed within a sleeve
  • FIG. 11 shows the ureteral device of FIG. 7 held in a compressed state with an adhesive
  • FIG. 12 depicts a step in a procedure for placing a ureteral device in accordance with the invention
  • FIG. 13 illustrates the ureteral device and associated components
  • FIG. 14 shows removal of a guidewire from the ureteral device
  • FIG. 15 illustrates the ureteral device in position within a dilated ureter
  • FIG. 16 illustrates a ureteral device within an undilated ureter
  • FIG. 17 illustrates the ureteral device of FIG. 16, after the ureter has dilated
  • FIG. 18 is a perspective view of a ureteral device in accordance with the present invention, shown in a contracted state;
  • FIG. 19 is a perspective view of the ureteral device of FIG. 18, shown in an expanded state
  • FIG. 20 is a perspective view of a ureteral device in accordance with the present invention, shown in an expanded state;
  • FIG. 21 is a perspective view of the ureteral device of FIG. 20, shown in an expanded state.
  • FIG. 22 is a perspective view of a ureteral device in accordance with the present invention, shown in an expanded state.
  • FIG. 1 is a perspective view of a ureteral device in accordance with the invention.
  • the ureteral device includes a body 10 having a first end portion 12 and a second end portion 14.
  • the ureteral device body and end portions are flexible enough to assume a substantially linear configuration. However, in a static state, the end portions of the ureteral device can assume a curved orientation as shown. Details regarding the features, exemplary dimensions, and use of the ureteral device follow.
  • FIG. 2 is a detailed view of a straightened first end portion 12 of an exemplary ureteral device.
  • the opposite, second end portion 14 (not shown in FIGS. 2-8) is substantially identical to the first end portion.
  • the ureteral device body and end portions have an "S" shaped cross-section. Apertures are provided along all or a portion of the length of the ureteral device. Although the apertures 16 are shown as being elongate, they can also be oval or circular.
  • the "S" shape of the ureteral device body and end portions defines two longitudinal channels 18 and 20. As used herein, a channel is a path defined, or at least partially bound, by a portion of the ureteral device body or end portions.
  • FIG. 3 illustrates the ureteral device in an "I" configuration. Although not illustrated other than FIG. 2, apertures can be provided in this and all other ureteral device configurations.
  • the "I" shape defines two longitudinal channels 22 and 24.
  • FIG. 4 illustrates the ureteral device configured to provide three channels 26, 28 and 30.
  • FIG. 5 illustrates the ureteral device configured to provide four channels 32, 34, 36 and 38. .
  • FIG. 6 also depicts the ureteral device that defines four channels 40, 42, 44 and 46.
  • FIG. 7 depicts a ureteral device with a single channel 48.
  • FIG. 8 illustrates a ureteral device having segments 50 joined by linking regions 52 and defining a channel 54.
  • the linking regions bias or urge adjacent segments away from coaxial alignment.
  • the channel(s) need not be linear and can be somewhat discontinuous or multiple channels are provided.
  • FIG. 9A illustrates a ureteral device having resilient, substantially-longitudinal elements 56.
  • the elements 56 are bowed outward from a central axis of the ureteral device, in a cage expanded state, to provide the ureteral device with an undulating surface and alternating larger and smaller localized circumferential regions.
  • FIG. 9B illustrates the ureteral device of FIG. 9 A with the elements 56 in a substantially linear or non- bowed configuration, a cage contracted state.
  • FIG. 9C depicts yet another embodiment of the ureteral device, wherein the ureteral device is substantially planar in a first configuration as shown. In the cage expanded state, elements 56' bow outward as shown with respect to the ureteral device of FIG.
  • FIG. 9D illustrates yet another embodiment, wherein an elongate flexible body is provided with barbs 59 that can be transitioned from a reduced diameter configuration 59 to a larger diameter configuration.
  • barbs 59 are shown in different configurations and states.
  • the ureteral devices of FIGS. 9A-D can be transitioned from a uniform/reduced diameter configuration to a nonuniform/larger diameter configuration by compressing the ureteral device longitudinally, or by removing a restraining force from outwardly biased elements 56 or 56'.
  • a restraining force is provided by a sleeve as shown with respect to FIG. 10 or with adhesives as described below with respect to FIG. 11.
  • FIG. 10 depicts the ureteral device of FIG. 3 within a sleeve 60. Because at least a portion of the ureteral device is flexible, such as body portions 62, 64, 66 and 68 that define the channels 22 and 24, the ureteral device can be folded into a sleeve having a smaller diameter than the ureteral device in its unfolded state. If the material of the ureteral device is compressible, the ureteral device can be placed into an even smaller diameter sleeve.
  • the sleeve 60 thus can serve at least two important functions: it temporarily reduces the diameter of the ureteral device and, until removal, it provides a smooth exterior surface. Both of these features facilitate deployment of the ureteral device as described below.
  • the ureteral device in a configuration such as shown in the sectional end view of FIG. 7 can be folded or rolled and held in that configuration with a water or acid soluble adhesive 70.
  • a water or acid soluble adhesive 70 dissolves; the ureteral device unfolds or unrolls.
  • Exemplary ureteral devices are made of silicone and have lengths in the range of 22 to 32 centimeters for adults and about 16 to 18 centimeters for children. However, the length of the ureteral device can be modified as required.
  • a ureteral device can have a diameter of about 7.0 FR for placement within a ureteral orifice 3 millimeters in diameter.
  • Ureteral devices as described herein are well suited for removal of a stone up to 10 millimeters in diameter.
  • FIG. 12 illustrates a step of an exemplary procedure, wherein a cystoscope has been used to find the orifice 72 of the ureter 74 leading between the bladder 76 and a kidney 77.
  • a flexible wire 78 such as is known in the art, has been guided through the orifice 72 and into the ureter.
  • a ureteral device 80 in accordance with the invention is selected, placed over the wire 78, and passed into the ureter 74.
  • a pusher 82 can be placed over the wire 78 and pressed against the proximal end 84 of the ureteral device 80.
  • the ureteral device 80 is compressed within a sleeve 86.
  • the pusher 82, if used, and the flexible wire 78 are then removed, as shown in FIG. 14, and the ureteral device is left in place. If a sleeve is used, it can also be removed from the ureteral device. However, as removal of a sleeve from a ureteral device can be difficult, especially if the ureteral device or portions thereof are compressed by the sleeve, the present invention provides a sleeve that degrades or dissolves to release the ureteral device therefrom.
  • the sleeve is made of a material that dissolves in urine within a few hours.
  • the material can be a water, base or acid soluble material such as sugars, polydioxanone, polyglecaprone 25, polyglactine, gelatine sponge, hylauronan-benzyl 15 ester hyaluronic acid, cyanoacrylate, chromic suture material and polyglycolic acid. Additionally, the material can be dissolvable by ultrasound.
  • a first curled end portion anchors a first end 82 of the ureteral device 80 within the bladder 76 and a second curled end portion anchors a second end 84 of the ureteral device within the kidney 77.
  • the ureter 74 dilates around the ureteral device naturally from a normal state as shown in FIG. 16 to an increased diameter or dilated state as illustrated in FIG. 17.
  • the ureteral device selected for insertion is a radially expandible ureteral device.
  • a stone may not have been able to pass through an undilated ureter, after dilation the stone (depending on its size) is able to pass through the increased diameter ureter.
  • the ureteral device is removed from the body. Any stones trapped in the channel(s) are removed with the ureteral device.
  • the channel(s) help to maximize a flow path for urine and they provide an enlarged path for the stones to wash into the bladder.
  • the open cross-section of the present ureteral device is not easily clogged.
  • the open channel configurations do not readily become pinched closed as do known complete, cylindrical, catheter-like tubes.
  • the ureteral device can be fabricated from a material that degrades into small pieces or dissolves so that it can be passed with urine.
  • the ureteral device can be made of a urine, water, acid, or base soluble material such as sugar, polydioxanone, polyglecaprone 25, polyglactine, gelatine sponge, hylauronan-benzyl ester hyaluronic acid, or cyanoacrylate.
  • the ureteral device can dissolve when exposed to ultrasound.
  • An exemplary ureteral device dissolves completely within a week or two. Even if dissolution of the ureteral device begins when the sleeve is removed, the rate of deterioration is slow enough so that the ureteral device will perform its intended purpose.
  • the ureteral device in accordance with the invention can be therapeutically effective with respect to obstruction, stricture and external compression of any tubular structure within the body including airways, bile ducts, pancreatic ducts, the bowel, blood vessels and the urethra.
  • FIG. 18 is perspective view of another embodiment of a ureteral device similar to the device shown in FIG. 9 A.
  • the ureteral device has a body 88 which includes a flexible tube 90, a body wall 92 with an outer surface and an inner surface that define a lumen 94.
  • the body wall 92 has a plurality of elongate flexible members, here exemplified by representative members, 96, 96', 96".
  • the elongate flexible members are arranged in groups of three radially-spaced members. The length of the elongate flexible members can be from slightly less than the full length of the body to less than 1 cm.
  • the length of the members is from 0.1 cm to 10.0 cm and in other embodiments, the length of the members is from 1.0 cm to 5.0 cm. Further, in some embodiments the lengths of the members is from 2.0 cm to 3.0 cm.
  • the length of the members may vary with the requirements of a given procedure or the size of an obstruction.
  • apertures 98, 98', 98" and apertures 100, 100', 100" which separate members from their adjacent neighboring members.
  • the apertures are shown as being elongate, they can also be oval, circular or may be slot-like as shown in FIG. 9.
  • the distance between the elongate members and their adjacent neighbors range from completely touching to not touching at all.
  • the body 88 has a substantially uniform diameter with a smooth exterior surface.
  • FIG. 19 the ureteral device of FIG. 18 is shown in an expanded state.
  • the elongate flexible members 96, 96", 96" arc away from each adjacent elongate flexible member thereby defining a plurality of cages 102, 102', 102" and void spaces 104, 104' and 104" along the body 88.
  • the elongate flexible members are in a spaced-apart relation with regard to adjacent elongate flexible members. While these figures show three elongate flexible members per cage, it will be readily understood that various numbers of members may be employed.
  • FIG. 20 shows a ureteral device with four elongate flexible members per cage in an expanded state.
  • the cages can be transitioned from a contracted state, as shown in FIG. 18, to an expanded state, as shown in FIGS. 19 and 20.
  • One way that this can be accomplished is by shortening the length of the body 88.
  • a filament 106 can be provided that is secured to a distal region 108 of the body 88 as shown in FIG. 20, wherein pulling the filament toward the proximal end 110 of the body 88 shortens the body causing the members to bow outward and form cages 102, 102' and 102".
  • the filament can be pulled free of the distal region 108 once sufficient force has been applied to deform flexible members that define the cage.
  • Another way to facilitate the transition of the cages from one state to the other is to construct the cages so that they are biased to take an expanded state.
  • the cages are then held in a contracted state by a restraining force as described in more detail above (e. g. sheaths or adhesives). Once the restraining force is removed, the cage will expand to expose the void spaces.
  • a restraining force as described in more detail above (e. g. sheaths or adhesives).
  • the proximal end of the device or a tether secured thereto can be pulled.
  • An exemplary tether 112 is shown in FIG. 19. In this embodiment, when the tether 112 is pulled, the device will transition from the expanded state to the contracted state. The pulling of one end of the device acts to lengthen the body, thereby contracting the cages.
  • the ureteral device When the ureteral device is in the contracted state it has a cage diameter that is less than a cage diameter when the device is in the expanded state.
  • the diameter in the contracted state can range from 1 mm to 5 mm and the diameter in the expanded state can range from 5 mm to 20 mm.
  • FIG. 21 is a perspective view of a ureteral device, in accordance with the invention, shown in a contracted state.
  • the elongate flexible members 96, 96', 96" are configured in a spiral pattern.
  • FIG. 22 shows the ureteral device of FIG. 21 in an expanded state.
  • the members are linear or other shapes, but not parallel to the longitudinal axis of the body 88.
  • FIGS. 18 - 22 An exemplary method of use of the ureteral device shown in FIGS. 18 - 22 is described as follows.
  • the ureteral device in a contracted state, is guided through a ureter in a retrograde manner. This may be accomplished by using a guidewire (as described above), by guiding the device directly or by other common means of device or catheter guidance.
  • a guidewire as described above
  • the natural expansion of the ureter combined with the exposed void spaces 104, 104', 104" in the device facilitate the migration of an occlusion into a void spaces.
  • the device When it is determined that a target occlusion (such as a stone) has lodged in the void space of the cage, the device can be induced to take a contracted state or pulled from the ureter, thereby contracting the cages.
  • the contracted state acts to compress and/or enclose the occlusion within the smooth body, facilitating removal.
  • the device is then removed from the ureter along with the "captured" occlusion.
  • intermediate steps may be employed in combination with those set forth here to facilitate removal of the occlusion. For example, combining a laser application step to break up the occlusion into smaller pieces may be employed. Many of the "traditional" techniques may be used in combination with the present invention as aids in the removal of the occlusion. Further, the device of the invention may be used to only expand the ureter, when such a procedure is desired.
  • a device body 88 made of a flexible tube is either formed with apertures 98, 98', 98" along its length or the apertures are cut into the flexible tube. These apertures define the edges of the flexible members 96, 96', 96".
  • the apertures may be of very small width, having zero tolerance, or may be expanded to form wider slots as seen in FIG. 9. It will be understood that the apertures may be formed longitudinally, non-longitudinally or in any other arrangement in accordance with the invention. Further, in one embodiment, the device is maintained in an expanded state while heat is applied to induce a shape memory effect in a material of the device.
  • the device is constructed of silicone, it is heated to a very high temperature and allowed to cool. Upon cooling, the device will hold the expanded state when at rest. Additionally, a sheath or adhesive can then be applied to hold the device in a contracted state until use.

Abstract

A ureteral device is provided for facilitating stone passage through a ureter or duct. An exemplary ureteral device includes a flexible, elongate body that defines a plurality of cages along the body. In a contracted state the cages have a reduced diameter. When an activation force is applied, the cages transform to an expanded state, thereby defining a plurality of void spaces. The void spaces are configured to receive an obstruction, such as a stone. The ureteral device can then be induced to the contracted state to compress the obstruction within the elongate, flexible body and then be removed from the obstructed passage. The ureteral device can be configured to have different numbers of elongate flexible members that define the cages.

Description

RADIALLY EXPANDING URETERAL DEVICE
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of U.S. application Serial No. 09/272,660, filed March 18, 1999.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH Not applicable.
FIELD OF THE INVENTION
The present invention relates to a medical device, and more particularly to a medical device for facilitating passage and/or removal of kidney stones.
BACKGROUND OF THE INVENTION
Calculus or stones in the urinary tract or kidneys usually arise because of the breakdown of a delicate balance in the body. Specifically, the kidneys must conserve water to function, but they must excrete materials that have a low solubility. These opposing requirements must be balanced during adaptation to diet, climate and activity. The problem is mitigated to some degree because urine contains substances that inhibit crystallization of stone forming minerals. However, when urine becomes supersaturated with insoluble materials, because excretion rates are excessive and/or because water conservation is extreme, crystals form and may grow and aggregate to form a stone.
Although small crystals are readily voided from the kidney with urine, the larger stones frequently become dislodged from the kidney and enter the ureter or occlude the uretero-pelvic junction, causing pain and obstruction. Although some stones can ultimately traverse the ureter, their passage usually produces pain and bleeding. Usually the pain is so severe that narcotic drugs are needed for its control.
Removal of stones from the kidneys or urinary tract can be effected medically or surgically. A well known surgical approach involves passing a flexible basket in a retrograde manner up the ureter from the bladder, and using the basket to capture the stones. Another surgical technique, known as extracorporeal lithotripsy, entails transmission of high-intensity shock waves from outside the body to fragment the stones v thin the body. The resulting stone fragments are then voided with urine. Yet another surgical technique, percutaneous ultrasonic lithotripsy, requires the passage of a rigid cystoscopy-like instrument in the renal pelvis through a small incision in the flank whereupon stones are broken up by a small ultrasound transducer and removed directly. Another surgical technique is laser lithotripsy via a ureteroscope. All of these procedures, which can be quite painful, are elaborate and expensive, and do not always result in complete removal of the stones and fragments.
Stents are used to decompress ureteral obstruction, ensuring that urine drains from the kidney to the bladder. It has also been recognized that placement of a stent within the ureter can help small stones and stone fragments to transit the ureter. In a typical procedure involving a stent, a guide wire is passed through the ureter to the renal pelvis. A hollow, flexible, cylindrical stent is then advanced with a pusher over the guide wire. The guide wire and pusher are then extracted from the stent and the body, leaving an open lumen for urine to pass through. However, because the lumen defined by the cylindrical stent is even smaller than the ureter itself, all but the smallest stones and sludge are precluded from passing therethrough. Some fragments are able to pass around the ureteral stent but larger stone fragments are unable to pass. In many cases, stone fragments often block the open stent passageway.
SUMMARY OF THE INVENTION
The present invention provides an improved ureteral device that is not only well- suited for decompressing an obstructed passage within the body such as a ureter, but which is also configured to gently dilate and thus facilitate stone passage through a ureter or duct.
In an exemplary embodiment a ureteral device includes a flexible, elongate body that defines an open channel along the body. At least a portion of the body is made of a resilient material, wherein the open channel defines a void volume. A retaining or compressive force applied to the resilient material causes the void volume to be reduced, or maintained in a reduced state, until the retaining or compressive force is removed or maintained in a reduced state, until the retaining or compressive force is removed. A sleeve, a wire, or an adhesive soluble in liquid or dissolvable by ultrasound can provide the retaining force. In some embodiments, a flexible, elongate body includes elements distributed along the body and that are movable from a first state to a second state to increase the diameter of the ureteral device from a first diameter to a second diameter.
In another embodiment, a flexible, elongate body defines a plurality of flexible elongate members which in turn define a plurality of cages. The cages are movable from a cage contracted state to a cage expanded state.
BRIEF DESCRIPTION OF THE DRAWINGS
A more complete understanding of the present invention, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
FIGS. 1 is a perspective view of a ureteral device in accordance with the present invention;
FIGS. 2 - 9D are detailed views of end portions of ureteral devices in accordance with present invention;
FIG. 10 illustrates the ureteral device of FIG. 3 compressed within a sleeve;
FIG. 11 shows the ureteral device of FIG. 7 held in a compressed state with an adhesive;
FIG. 12 depicts a step in a procedure for placing a ureteral device in accordance with the invention;
FIG. 13 illustrates the ureteral device and associated components;
FIG. 14 shows removal of a guidewire from the ureteral device;
FIG. 15 illustrates the ureteral device in position within a dilated ureter;
FIG. 16 illustrates a ureteral device within an undilated ureter;
FIG. 17 illustrates the ureteral device of FIG. 16, after the ureter has dilated;
FIG. 18 is a perspective view of a ureteral device in accordance with the present invention, shown in a contracted state;
FIG. 19 is a perspective view of the ureteral device of FIG. 18, shown in an expanded state; FIG. 20 is a perspective view of a ureteral device in accordance with the present invention, shown in an expanded state;
FIG. 21 is a perspective view of the ureteral device of FIG. 20, shown in an expanded state; and
FIG. 22 is a perspective view of a ureteral device in accordance with the present invention, shown in an expanded state.
DETAILED DESCRIPTION OF THE INVENTION
FIG. 1 is a perspective view of a ureteral device in accordance with the invention. The ureteral device includes a body 10 having a first end portion 12 and a second end portion 14. The ureteral device body and end portions are flexible enough to assume a substantially linear configuration. However, in a static state, the end portions of the ureteral device can assume a curved orientation as shown. Details regarding the features, exemplary dimensions, and use of the ureteral device follow.
FIG. 2 is a detailed view of a straightened first end portion 12 of an exemplary ureteral device. The opposite, second end portion 14 (not shown in FIGS. 2-8) is substantially identical to the first end portion. In this view, the ureteral device body and end portions have an "S" shaped cross-section. Apertures are provided along all or a portion of the length of the ureteral device. Although the apertures 16 are shown as being elongate, they can also be oval or circular. The "S" shape of the ureteral device body and end portions defines two longitudinal channels 18 and 20. As used herein, a channel is a path defined, or at least partially bound, by a portion of the ureteral device body or end portions.
FIG. 3 illustrates the ureteral device in an "I" configuration. Although not illustrated other than FIG. 2, apertures can be provided in this and all other ureteral device configurations. The "I" shape defines two longitudinal channels 22 and 24.
FIG. 4 illustrates the ureteral device configured to provide three channels 26, 28 and 30.
FIG. 5 illustrates the ureteral device configured to provide four channels 32, 34, 36 and 38. .
FIG. 6 also depicts the ureteral device that defines four channels 40, 42, 44 and 46.
FIG. 7 depicts a ureteral device with a single channel 48. FIG. 8 illustrates a ureteral device having segments 50 joined by linking regions 52 and defining a channel 54. In one embodiment, the linking regions bias or urge adjacent segments away from coaxial alignment. Thus, the channel(s) need not be linear and can be somewhat discontinuous or multiple channels are provided.
FIG. 9A illustrates a ureteral device having resilient, substantially-longitudinal elements 56. In the illustration, the elements 56 are bowed outward from a central axis of the ureteral device, in a cage expanded state, to provide the ureteral device with an undulating surface and alternating larger and smaller localized circumferential regions. FIG. 9B illustrates the ureteral device of FIG. 9 A with the elements 56 in a substantially linear or non- bowed configuration, a cage contracted state. FIG. 9C depicts yet another embodiment of the ureteral device, wherein the ureteral device is substantially planar in a first configuration as shown. In the cage expanded state, elements 56' bow outward as shown with respect to the ureteral device of FIG. 9 A. FIG. 9D illustrates yet another embodiment, wherein an elongate flexible body is provided with barbs 59 that can be transitioned from a reduced diameter configuration 59 to a larger diameter configuration. In the illustration, barbs 59 are shown in different configurations and states. The ureteral devices of FIGS. 9A-D can be transitioned from a uniform/reduced diameter configuration to a nonuniform/larger diameter configuration by compressing the ureteral device longitudinally, or by removing a restraining force from outwardly biased elements 56 or 56'. In exemplary embodiments a restraining force is provided by a sleeve as shown with respect to FIG. 10 or with adhesives as described below with respect to FIG. 11.
FIG. 10 depicts the ureteral device of FIG. 3 within a sleeve 60. Because at least a portion of the ureteral device is flexible, such as body portions 62, 64, 66 and 68 that define the channels 22 and 24, the ureteral device can be folded into a sleeve having a smaller diameter than the ureteral device in its unfolded state. If the material of the ureteral device is compressible, the ureteral device can be placed into an even smaller diameter sleeve. The sleeve 60 thus can serve at least two important functions: it temporarily reduces the diameter of the ureteral device and, until removal, it provides a smooth exterior surface. Both of these features facilitate deployment of the ureteral device as described below.
Alternatively, as shown in FIG. 11, the ureteral device in a configuration such as shown in the sectional end view of FIG. 7 can be folded or rolled and held in that configuration with a water or acid soluble adhesive 70. Thus, when the adhesive dissolves; the ureteral device unfolds or unrolls.
Exemplary ureteral devices are made of silicone and have lengths in the range of 22 to 32 centimeters for adults and about 16 to 18 centimeters for children. However, the length of the ureteral device can be modified as required. A ureteral device can have a diameter of about 7.0 FR for placement within a ureteral orifice 3 millimeters in diameter. Ureteral devices as described herein are well suited for removal of a stone up to 10 millimeters in diameter.
FIG. 12 illustrates a step of an exemplary procedure, wherein a cystoscope has been used to find the orifice 72 of the ureter 74 leading between the bladder 76 and a kidney 77. A flexible wire 78, such as is known in the art, has been guided through the orifice 72 and into the ureter. A ureteral device 80 in accordance with the invention is selected, placed over the wire 78, and passed into the ureter 74.
As illustrated in FIG. 13, a pusher 82 can be placed over the wire 78 and pressed against the proximal end 84 of the ureteral device 80. In this illustration, the ureteral device 80 is compressed within a sleeve 86.
The pusher 82, if used, and the flexible wire 78 are then removed, as shown in FIG. 14, and the ureteral device is left in place. If a sleeve is used, it can also be removed from the ureteral device. However, as removal of a sleeve from a ureteral device can be difficult, especially if the ureteral device or portions thereof are compressed by the sleeve, the present invention provides a sleeve that degrades or dissolves to release the ureteral device therefrom. In an exemplary embodiment, the sleeve is made of a material that dissolves in urine within a few hours. The material can be a water, base or acid soluble material such as sugars, polydioxanone, polyglecaprone 25, polyglactine, gelatine sponge, hylauronan-benzyl 15 ester hyaluronic acid, cyanoacrylate, chromic suture material and polyglycolic acid. Additionally, the material can be dissolvable by ultrasound.
When the wire and sleeve are removed, the relatively unconfined ends of the ureteral device form a retention shape, such as by curling to form a "double- J," as is known in the art, and as shown in FIG. 15. A first curled end portion (or "J") anchors a first end 82 of the ureteral device 80 within the bladder 76 and a second curled end portion anchors a second end 84 of the ureteral device within the kidney 77. When the ureteral device 80 is in place, the ureter 74 dilates around the ureteral device naturally from a normal state as shown in FIG. 16 to an increased diameter or dilated state as illustrated in FIG. 17. The effect is particularly evident when the ureteral device selected for insertion is a radially expandible ureteral device. Although a stone may not have been able to pass through an undilated ureter, after dilation the stone (depending on its size) is able to pass through the increased diameter ureter. After the stone(s) have been eliminated from the body, the ureteral device is removed from the body. Any stones trapped in the channel(s) are removed with the ureteral device. The channel(s) help to maximize a flow path for urine and they provide an enlarged path for the stones to wash into the bladder. By contrast with known cylindrical ureteral devices, the open cross-section of the present ureteral device is not easily clogged. Furthermore, the open channel configurations do not readily become pinched closed as do known complete, cylindrical, catheter-like tubes.
Instead of removing the ureteral device using techniques known to those skilled in the art, the ureteral device can be fabricated from a material that degrades into small pieces or dissolves so that it can be passed with urine. The ureteral device can be made of a urine, water, acid, or base soluble material such as sugar, polydioxanone, polyglecaprone 25, polyglactine, gelatine sponge, hylauronan-benzyl ester hyaluronic acid, or cyanoacrylate. Alternatively, the ureteral device can dissolve when exposed to ultrasound. An exemplary ureteral device dissolves completely within a week or two. Even if dissolution of the ureteral device begins when the sleeve is removed, the rate of deterioration is slow enough so that the ureteral device will perform its intended purpose.
In addition to placement in a ureter, the ureteral device in accordance with the invention can be therapeutically effective with respect to obstruction, stricture and external compression of any tubular structure within the body including airways, bile ducts, pancreatic ducts, the bowel, blood vessels and the urethra.
FIG. 18 is perspective view of another embodiment of a ureteral device similar to the device shown in FIG. 9 A. The ureteral device has a body 88 which includes a flexible tube 90, a body wall 92 with an outer surface and an inner surface that define a lumen 94. The body wall 92 has a plurality of elongate flexible members, here exemplified by representative members, 96, 96', 96". The elongate flexible members are arranged in groups of three radially-spaced members. The length of the elongate flexible members can be from slightly less than the full length of the body to less than 1 cm. In some embodiments, the length of the members is from 0.1 cm to 10.0 cm and in other embodiments, the length of the members is from 1.0 cm to 5.0 cm. Further, in some embodiments the lengths of the members is from 2.0 cm to 3.0 cm. The length of the members may vary with the requirements of a given procedure or the size of an obstruction.
Along the members 96, 96', 96" are apertures 98, 98', 98" and apertures 100, 100', 100", which separate members from their adjacent neighboring members. Although the apertures are shown as being elongate, they can also be oval, circular or may be slot-like as shown in FIG. 9. When in a contracted state, the distance between the elongate members and their adjacent neighbors range from completely touching to not touching at all. Also as shown in FIG. 18, when the members are in a contracted state, the body 88 has a substantially uniform diameter with a smooth exterior surface.
Turning now to FIG. 19, the ureteral device of FIG. 18 is shown in an expanded state. When in the expanded state, the elongate flexible members 96, 96", 96" arc away from each adjacent elongate flexible member thereby defining a plurality of cages 102, 102', 102" and void spaces 104, 104' and 104" along the body 88. In the expanded state, the elongate flexible members are in a spaced-apart relation with regard to adjacent elongate flexible members. While these figures show three elongate flexible members per cage, it will be readily understood that various numbers of members may be employed. For example, FIG. 20 shows a ureteral device with four elongate flexible members per cage in an expanded state.
The cages can be transitioned from a contracted state, as shown in FIG. 18, to an expanded state, as shown in FIGS. 19 and 20. One way that this can be accomplished is by shortening the length of the body 88. For example, by pushing one or both ends of the body 88 axially to shorten the distance between the two ends. Alternatively, a filament 106 can be provided that is secured to a distal region 108 of the body 88 as shown in FIG. 20, wherein pulling the filament toward the proximal end 110 of the body 88 shortens the body causing the members to bow outward and form cages 102, 102' and 102". To prevent the filament 106 from obstructing the cages, the filament can be pulled free of the distal region 108 once sufficient force has been applied to deform flexible members that define the cage.
Another way to facilitate the transition of the cages from one state to the other, is to construct the cages so that they are biased to take an expanded state. The cages are then held in a contracted state by a restraining force as described in more detail above (e. g. sheaths or adhesives). Once the restraining force is removed, the cage will expand to expose the void spaces. When removal of the device is desired, the proximal end of the device or a tether secured thereto can be pulled. An exemplary tether 112 is shown in FIG. 19. In this embodiment, when the tether 112 is pulled, the device will transition from the expanded state to the contracted state. The pulling of one end of the device acts to lengthen the body, thereby contracting the cages.
When the ureteral device is in the contracted state it has a cage diameter that is less than a cage diameter when the device is in the expanded state. The diameter in the contracted state can range from 1 mm to 5 mm and the diameter in the expanded state can range from 5 mm to 20 mm.
FIG. 21 is a perspective view of a ureteral device, in accordance with the invention, shown in a contracted state. In this embodiment, the elongate flexible members 96, 96', 96" are configured in a spiral pattern. FIG. 22 shows the ureteral device of FIG. 21 in an expanded state. In another embodiment, the members are linear or other shapes, but not parallel to the longitudinal axis of the body 88.
An exemplary method of use of the ureteral device shown in FIGS. 18 - 22 is described as follows. The ureteral device, in a contracted state, is guided through a ureter in a retrograde manner. This may be accomplished by using a guidewire (as described above), by guiding the device directly or by other common means of device or catheter guidance. Once the device is in a desired location in the ureter, it is induced to take an expanded state or a restraining force is removed allowing it to assume an expanded state, as described above. The natural expansion of the ureter combined with the exposed void spaces 104, 104', 104" in the device facilitate the migration of an occlusion into a void spaces. When it is determined that a target occlusion (such as a stone) has lodged in the void space of the cage, the device can be induced to take a contracted state or pulled from the ureter, thereby contracting the cages. The contracted state acts to compress and/or enclose the occlusion within the smooth body, facilitating removal. The device is then removed from the ureter along with the "captured" occlusion. It will be understood by those skilled in the art that intermediate steps may be employed in combination with those set forth here to facilitate removal of the occlusion. For example, combining a laser application step to break up the occlusion into smaller pieces may be employed. Many of the "traditional" techniques may be used in combination with the present invention as aids in the removal of the occlusion. Further, the device of the invention may be used to only expand the ureter, when such a procedure is desired.
The device described in FIG. 18-22 is made in the following manner. A device body 88 made of a flexible tube, is either formed with apertures 98, 98', 98" along its length or the apertures are cut into the flexible tube. These apertures define the edges of the flexible members 96, 96', 96". The apertures may be of very small width, having zero tolerance, or may be expanded to form wider slots as seen in FIG. 9. It will be understood that the apertures may be formed longitudinally, non-longitudinally or in any other arrangement in accordance with the invention. Further, in one embodiment, the device is maintained in an expanded state while heat is applied to induce a shape memory effect in a material of the device. For example, if the device is constructed of silicone, it is heated to a very high temperature and allowed to cool. Upon cooling, the device will hold the expanded state when at rest. Additionally, a sheath or adhesive can then be applied to hold the device in a contracted state until use.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described herein above, and that the drawings are not to scale. A variety of modifications and variations are possible in light of the above teachings without departing from the scope and spirit of the invention, which is limited only by the following claims.

Claims

What is claimed is:
1. A ureteral device comprising: a flexible elongate body having a first end and a second end, the flexible elongate body defining a plurality of cages between the first end and the second end.
2. The ureteral device of claim 1, wherein the cages are reversibly, radially expandable.
3. The ureteral device of claim 1 , wherein the cages are defined by a plurality of elongate flexible members.
4. The ureteral device of claim 3, wherein the cages are transitionable from a contracted to an expanded state, and wherein the contracted state provides a first cage diameter and the expanded state provides a second cage diameter.
5. The ureteral device of claim 3, wherein the flexible elongate body includes a flexible tube having a body wall with an outer surface and an inner surface that defines a lumen, and wherein the plurality of elongate flexible members are defined by portions of the body wall.
6. The ureteral device of claim 5, wherein the elongate flexible members touch adjacent elongate flexible members when the plurality of cages are in a contracted state.
7. The ureteral device of claim 6, wherein the elongate flexible members are separated from each other when the plurality of cages are in an expanded state.
8. The ureteral device of claim 5, wherein the elongate flexible members are disposed in a spaced-apart relationship when the plurality of cages are in a contracted state.
9. The ureteral device of claim 3, wherein the elongate flexible members are longitudinally aligned with a longitudinal axis of the flexible elongate body.
10. The ureteral device of claim 3, wherein the elongate flexible members are not longitudinally aligned with a longitudinal axis of the flexible elongate body.
11. The ureteral device of claim 1 , wherein the elongate flexible body provides an undulating surface and alternating larger and smaller localized circumferential regions.
12. A ureteral device comprising : a flexible elongate body having a first end and a second end, the flexible elongate body defining a plurality of cages between the first end and the second end, wherein the cages are defined by a plurality of elongate flexible members, and wherein the cages are reversibly, radially expandable.
13. A method of removing a ureteral obstruction, comprising the steps of:
(a) providing a device having a flexible elongate body having a first end and a second end, the flexible elongate body defining a plurality of cages between the first end and the second end;
(b) guiding the device in a retrograde manner through a ureter;
(c) expanding the device to allow an obstruction to lodge therein; and
(d) removing the device from the ureter.
14. A method of dilating a duct, comprising the steps of:
(a) providing a device having a flexible elongate body having a first end and a second end, the flexible elongate body defining a plurality of cages between the first end and the second end;
(b) guiding the device in a retrograde manner through a ureter; and
(c) expanding the device.
15. A method of making a ureteral device, comprising the steps of:
(a) providing an elongate flexible body with a body wall which defines a central lumen; and
(b) creating a plurality of apertures in the body wall such that the apertures completely penetrate a cross-section of the body wall; and
(c) creating the apertures such that elongate flexible members are defined by the apertures in the body wall.
16. The method of claim 15, further comprising removing portions of the body wall adjacent to the apertures.
17. The method of claim 15, wherein the apertures are radially spaced on the body wall.
18. The method of claim 15, further comprising the steps of:
(d) expanding the elongate flexible members to an expanded state; and
(e) heating the ureteral device to a temperature sufficient to induce a shape memory of the expanded state.
PCT/US2001/024409 2001-01-05 2001-08-02 Radially expanding ureteral device WO2002053065A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01961878A EP1347716B1 (en) 2001-01-05 2001-08-02 Radially expanding ureteral device
DE60133834T DE60133834T2 (en) 2001-01-05 2001-08-02 RADIAL EXPANDABLE DEVICE FOR THE TUBE
CA2431652A CA2431652C (en) 2001-01-05 2001-08-02 Open channel stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/755,487 US6709465B2 (en) 1999-03-18 2001-01-05 Radially expanding ureteral device
US09/755,487 2001-01-05

Publications (1)

Publication Number Publication Date
WO2002053065A1 true WO2002053065A1 (en) 2002-07-11

Family

ID=25039359

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/024409 WO2002053065A1 (en) 2001-01-05 2001-08-02 Radially expanding ureteral device

Country Status (6)

Country Link
US (3) US6709465B2 (en)
EP (1) EP1347716B1 (en)
AT (1) ATE393605T1 (en)
CA (1) CA2431652C (en)
DE (1) DE60133834T2 (en)
WO (1) WO2002053065A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007037797A (en) * 2005-08-03 2007-02-15 Vector Kk Stent for ureter

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL128261A0 (en) 1999-01-27 1999-11-30 Disc O Tech Medical Tech Ltd Expandable element
US7621950B1 (en) * 1999-01-27 2009-11-24 Kyphon Sarl Expandable intervertebral spacer
US6709465B2 (en) 1999-03-18 2004-03-23 Fossa Medical, Inc. Radially expanding ureteral device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
CN1835720B (en) * 2001-07-25 2011-09-28 Disc整形外科技术股份有限公司 Deformable tools and implants
WO2004032795A2 (en) * 2002-10-09 2004-04-22 Fossa Medical, Inc. Eccentric lumen stents
US9333102B2 (en) * 2003-02-24 2016-05-10 Allium Medical Solutions Ltd. Stent
US7025779B2 (en) * 2003-02-26 2006-04-11 Scimed Life Systems, Inc. Endoluminal device having enhanced affixation characteristics
AU2003214708A1 (en) 2003-03-14 2004-09-30 Roque Humberto Ferreyro Irigoyen Hydraulic device for the injection of bone cement in percutaneous vertebroplasty
EP1605863B1 (en) 2003-03-14 2016-09-07 Intersect ENT, Inc. Sinus delivery of sustained release therapeutics
US8066713B2 (en) 2003-03-31 2011-11-29 Depuy Spine, Inc. Remotely-activated vertebroplasty injection device
US8303642B1 (en) * 2003-05-23 2012-11-06 Advanced Cardiovascular Systems, Inc. Metal injection molded tubing for drug eluting stents
US8415407B2 (en) 2004-03-21 2013-04-09 Depuy Spine, Inc. Methods, materials, and apparatus for treating bone and other tissue
WO2006011152A2 (en) 2004-06-17 2006-02-02 Disc-O-Tech Medical Technologies, Ltd. Methods for treating bone and other tissue
US8579908B2 (en) 2003-09-26 2013-11-12 DePuy Synthes Products, LLC. Device for delivering viscous material
US20050143678A1 (en) 2003-10-14 2005-06-30 Pluromed, Inc. Confinement of kidney-stone fragments during lithotripsy
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US8585771B2 (en) * 2004-02-26 2013-11-19 Endosphere, Inc. Methods and devices to curb appetite and/or to reduce food intake
US7507218B2 (en) * 2004-04-26 2009-03-24 Gyrus Acmi, Inc. Stent with flexible elements
US7470247B2 (en) * 2004-04-26 2008-12-30 Gyrus Acmi, Inc. Ureteral stent
US20050240278A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent improvements
US20050240141A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent kidney curl improvements
US7462183B2 (en) * 2004-07-07 2008-12-09 Percutaneous Systems, Inc. Methods for deploying conformed structures in body lumens
US7883516B2 (en) * 2004-07-07 2011-02-08 Percutaneous Systems, Inc. Methods for removing kidney stones from the ureter
US7972292B2 (en) 2005-07-06 2011-07-05 Percutaneous Systems, Inc. Methods and apparatus for deploying ureteral stents
US9655633B2 (en) * 2004-09-10 2017-05-23 Penumbra, Inc. System and method for treating ischemic stroke
US8366735B2 (en) 2004-09-10 2013-02-05 Penumbra, Inc. System and method for treating ischemic stroke
US7317331B2 (en) * 2004-11-08 2008-01-08 Tabula, Inc. Reconfigurable IC that has sections running at different reconfiguration rates
EP2298318A1 (en) 2005-04-04 2011-03-23 Sinexus, Inc. Device and methods for treating paranasal sinus conditions
DE102005019649A1 (en) * 2005-04-26 2006-11-02 Alveolus Inc. Flexible stent for positioning in lumen of esophagus comprises tube and stabilization members defined circumferentially about tube, where each member extends inwardly in tube to define inner diameter that is less than inner diameter of tube
BRPI0611278A2 (en) 2005-05-02 2010-08-31 Gen Hospital Corp lithiasis treatment without lithotripsy
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9381024B2 (en) 2005-07-31 2016-07-05 DePuy Synthes Products, Inc. Marked tools
US9918767B2 (en) 2005-08-01 2018-03-20 DePuy Synthes Products, Inc. Temperature control system
US8360629B2 (en) 2005-11-22 2013-01-29 Depuy Spine, Inc. Mixing apparatus having central and planetary mixing elements
US8828091B2 (en) * 2006-03-23 2014-09-09 Boston Scientific Scimed, Inc. Movable stent reinforcement
EP2068898A4 (en) * 2006-09-14 2011-07-20 Depuy Spine Inc Bone cement and methods of use thereof
US9585989B2 (en) * 2006-09-19 2017-03-07 Boston Scientific Scimed, Inc. Ureteral stent having variable hardness
US7713308B2 (en) * 2006-09-22 2010-05-11 Boston Scientific Scimed, Inc. Stent with soluble bladder retention member
CN102159143A (en) * 2006-09-29 2011-08-17 普拉罗美德公司 Methods for preventing retropulsion of concretions and fragments during lithotripsy
ES2587573T3 (en) 2006-10-19 2016-10-25 Depuy Spine, Inc. Fluid release system and related method
US10076346B2 (en) 2007-04-17 2018-09-18 Covidien Lp Complex wire formed devices
US20100274246A1 (en) * 2007-05-10 2010-10-28 Oren Globerman Expandable intramedullary nail for small bone fixation
US8956419B2 (en) * 2007-05-14 2015-02-17 Boston Scientific Scimed, Inc. Open lumen stent
US7879066B2 (en) * 2007-07-13 2011-02-01 Percutaneous Sustems, Inc. Apparatus for occluding body lumens
US8475489B2 (en) * 2007-07-13 2013-07-02 Percutaneous Systems, Inc. Apparatus for occluding body lumens
US20090054934A1 (en) * 2007-07-25 2009-02-26 Depuy Spine, Inc. Expandable fillers for bone cement
US8425449B2 (en) 2009-07-09 2013-04-23 Ivantis, Inc. Ocular implants and methods for delivering ocular implants into the eye
US20170360609A9 (en) 2007-09-24 2017-12-21 Ivantis, Inc. Methods and devices for increasing aqueous humor outflow
EP2231065B8 (en) 2007-12-18 2021-01-06 Intersect ENT, Inc. Self-expanding devices
EP2259833A1 (en) * 2008-03-05 2010-12-15 Ivantis, INC. Methods and apparatus for treating glaucoma
JP5610542B2 (en) 2008-04-21 2014-10-22 コヴィディエン リミテッド パートナーシップ Blade ball embolization device and delivery system
US8241316B2 (en) * 2008-04-25 2012-08-14 Paul Oberle Inflatable nasopharyngeal stent
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
WO2009140209A1 (en) * 2008-05-16 2009-11-19 Percutaneous Systems, Inc. Systems and methods for stone removal
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
US8763222B2 (en) 2008-08-01 2014-07-01 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
JP2012502746A (en) * 2008-09-16 2012-02-02 シー.アール.バード,インコーポレイテッド Stent
WO2010041039A1 (en) 2008-10-10 2010-04-15 Veryan Medical Limited A medical device suitable for location in a body lumen
US9539120B2 (en) * 2008-10-10 2017-01-10 Veryan Medical Ltd. Medical device suitable for location in a body lumen
CN104274256A (en) * 2008-11-04 2015-01-14 坦吉恩股份有限公司 Cell-scaffold constructs
EP2355717B1 (en) 2008-12-01 2014-02-19 Percutaneous Systems, Inc. Systems for capturing and removing urinary stones from body cavities
US8348856B1 (en) 2008-12-16 2013-01-08 Zanetta Malanowska-Stega Simultaneous multiple method out-patient uterus biopsy device and method
US10456276B2 (en) * 2009-05-08 2019-10-29 Veryan Medical Limited Medical device suitable for location in a body lumen
EP2248490A1 (en) * 2009-05-08 2010-11-10 Veryan Medical Limited A medical device suitable for location in a body lumen
EP2429624B1 (en) 2009-05-15 2014-04-02 Intersect ENT, Inc. A combination of an expandable device and a delivery device.
KR20120047231A (en) * 2009-06-17 2012-05-11 트리니티 올쏘피딕스, 엘엘씨 Expanding intervertebral device and methods of use
US9693899B2 (en) 2009-07-09 2017-07-04 Ivantis, Inc. Single operator device for delivering an ocular implant
WO2011094638A1 (en) 2010-01-28 2011-08-04 Micro Therapeutics, Inc. Vascular remodeling device
US8920513B2 (en) * 2010-08-27 2014-12-30 Thomas W. Rickner Anti-refluxive and trigone sparing internal ureteral stent
WO2012052982A1 (en) 2010-10-22 2012-04-26 Neuravi Limited Clot engagement and removal system
US20140081415A1 (en) * 2010-12-07 2014-03-20 The Brigham And Women's Hospital, Inc. Microvascular anastomotic coupler and methods of using same
CA2825774C (en) 2011-02-11 2017-02-28 Frank P. Becking Two-stage deployment aneurysm embolization devices
RU2460480C1 (en) * 2011-03-04 2012-09-10 Алексей Анатольевич Соколов Device for preventing migration of stone and its fragments in process of contact lithotripsy
EP2688736B1 (en) 2011-03-22 2017-11-29 Applied Medical Resources Corporation Method of making medical tubing having drainage holes
WO2012134990A1 (en) 2011-03-25 2012-10-04 Tyco Healthcare Group Lp Vascular remodeling device
US20120289994A1 (en) * 2011-05-12 2012-11-15 Boston Scientific Scimed, Inc. Occlusion Devices and Related Methods of Use
US20130123934A1 (en) * 2011-05-13 2013-05-16 Riad Azar Grooved pancreatic stent
WO2013049448A1 (en) 2011-09-29 2013-04-04 Covidien Lp Vascular remodeling device
FR2995523A1 (en) * 2012-09-18 2014-03-21 Ct Hospitalier Universitaire Rouen ENDO-URETHRAL PROSTHESIS
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
WO2014085450A1 (en) 2012-11-28 2014-06-05 Ivantis, Inc. Apparatus for delivering ocular implants into an anterior chamber of the eye
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
EP2948073A4 (en) 2013-01-22 2016-12-21 Percutaneous Systems Inc Ureteral stent and method and system for its deployment
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
AU2014236729B2 (en) 2013-03-14 2018-11-22 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
TR201820525T4 (en) 2013-03-14 2019-01-21 Neuravi Ltd A clot removal device for removing an occlusive clot from a blood vessel.
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
CN105142545B (en) 2013-03-15 2018-04-06 柯惠有限合伙公司 Locking device
US9980715B2 (en) 2014-02-05 2018-05-29 Trinity Orthopedics, Llc Anchor devices and methods of use
EP3062863B1 (en) 2014-04-04 2019-06-12 Gyrus ACMI, Inc. (d.b.a.Olympus Surgical Technologies America) Ureteral stent with anti-migration features
JP2017510370A (en) * 2014-04-11 2017-04-13 コロプラスト アクティーゼルスカブ Ureteral stent
WO2015154782A1 (en) * 2014-04-11 2015-10-15 Coloplast A/S A ureteral stent
ES2920773T3 (en) 2014-11-26 2022-08-09 Neuravi Ltd A clot removal device to remove an occlusive clot from a blood vessel
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
BR112017024922A2 (en) * 2015-05-20 2018-07-31 Innoventions Ltd stent and method of use
US10493232B2 (en) 2015-07-20 2019-12-03 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
EP3325078B1 (en) 2015-07-20 2020-02-12 Strataca Systems Limited Ureteral and bladder catheters
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US10765834B2 (en) 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
WO2017019974A1 (en) * 2015-07-29 2017-02-02 Renastent Llc Transformable ureteral stent
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
MX2019006793A (en) 2016-12-09 2019-11-18 Zanetta Malanowska Stega Brush biopsy device, kit and method.
WO2018119477A1 (en) 2016-12-23 2018-06-28 Ganz Alexander S Obesity treatment devices, systems, and methods
US11464660B2 (en) 2016-12-23 2022-10-11 Ganz Brake, Llc Obesity treatment devices, systems, and methods
WO2018200050A1 (en) 2017-04-25 2018-11-01 Strataca Systems Limited Systems, Kits and Methods for Inducing Negative Pressure to Increase Renal Function
EP3615124A4 (en) 2017-04-25 2021-01-06 Strataca Systems Limited Catheter and method for inducing negative pressure in a patient's bladder
EP3624729A1 (en) 2017-05-19 2020-03-25 Mayo Foundation for Medical Education and Research Methods and materials for treating urinary calculi
US10933227B2 (en) 2017-12-01 2021-03-02 Gyrus Acmi, Inc. Ureteral stent
US11039914B2 (en) 2018-10-22 2021-06-22 Sevro Technologies Llc Variable length stent
TW202034864A (en) 2018-11-30 2020-10-01 馬爾他商史翠塔卡系統有限公司 Percutaneous urinary catheter
JP2022515321A (en) 2018-11-30 2022-02-18 ロイヴィオス リミテッド Coated and / or impregnated ureteral catheter or stent and method
TW202034863A (en) 2018-11-30 2020-10-01 馬爾他商史翠塔卡系統有限公司 Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
CN113710171A (en) * 2019-02-08 2021-11-26 保形医疗公司 Device and method for removing left atrial appendage
IT201900013206A1 (en) * 2019-07-29 2021-01-29 Euromedical S R L STENT AND RELATED INSERTION DEVICE
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US20210370019A1 (en) 2020-05-28 2021-12-02 Strataca Systems Limited Method of Treatment Using Negative Pressure Renal Therapy and Medicament(s)
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
CN114602035A (en) * 2021-05-08 2022-06-10 宁波市第一医院 Anti-blocking support tube with vanishing film
WO2022237108A1 (en) * 2021-05-08 2022-11-17 宁波市第一医院 Anti-blocking nephrostomy tube and curved drainage nephrostomy tube
WO2022236933A1 (en) * 2021-05-08 2022-11-17 宁波市第一医院 Micro-groove drainage stent tube, anti-blocking stent tube having vanishing membrane, and anti-blocking stent tube kit

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973301A (en) * 1989-07-11 1990-11-27 Israel Nissenkorn Catheter and method of using same
US5129910A (en) * 1991-07-26 1992-07-14 The Regents Of The University Of California Stone expulsion stent

Family Cites Families (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US894198A (en) 1908-03-20 1908-07-28 Emma J Funk Instrument to cure gapes.
US3108593A (en) * 1961-03-13 1963-10-29 Jacob A Glassman Surgical extractor
US3108594A (en) * 1962-08-14 1963-10-29 Jacob A Glassman Surgical extractor and method of use
US4046149A (en) * 1975-01-31 1977-09-06 Olympus Optical Co., Ltd. Instrument for removing a foreign substance from the body cavity of human being
US4307723A (en) 1978-04-07 1981-12-29 Medical Engineering Corporation Externally grooved ureteral stent
US4531933A (en) 1982-12-07 1985-07-30 C. R. Bard, Inc. Helical ureteral stent
US4671795A (en) 1984-11-19 1987-06-09 Mulchin William L Permanent/retrievable ureteral catheter
US4874360A (en) 1988-07-01 1989-10-17 Medical Engineering Corporation Ureteral stent system
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5456251A (en) 1988-08-26 1995-10-10 Mountpelier Investments, S.A. Remote sensing tonometric catheter apparatus and method
CA1322628C (en) * 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US6171338B1 (en) * 1988-11-10 2001-01-09 Biocon, Oy Biodegradable surgical implants and devices
JP2984056B2 (en) 1989-09-08 1999-11-29 ボストン サイエンティフィック コーポレイション Physiological low pressure angioplasty
US5454365A (en) * 1990-11-05 1995-10-03 Bonutti; Peter M. Mechanically expandable arthroscopic retractors
US4990133A (en) 1990-04-02 1991-02-05 Tenax-Glynn Corporation Removable J-J ureteral stent
US5052998A (en) 1990-04-04 1991-10-01 Zimmon David S Indwelling stent and method of use
US5221261A (en) 1990-04-12 1993-06-22 Schneider (Usa) Inc. Radially expandable fixation member
IL94138A (en) * 1990-04-19 1997-03-18 Instent Inc Device for the treatment of constricted fluid conducting ducts
DE59106425D1 (en) 1990-12-07 1995-10-12 Ruesch Willy Ag Ureteral catheter.
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5464450A (en) 1991-10-04 1995-11-07 Scimed Lifesystems Inc. Biodegradable drug delivery vascular stent
WO1993006792A1 (en) 1991-10-04 1993-04-15 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5282784A (en) 1991-10-09 1994-02-01 Mentor Corporation Injection stent system
CA2079417C (en) 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
IT1254480B (en) 1992-02-28 1995-09-25 DEVICE TO ELIMINATE OCCLUSIONS OF FRAGMENTS OF CALCULATIONS PRESENT IN THE URINARY SYSTEM
US5569184A (en) 1992-04-29 1996-10-29 Cardiovascular Dynamics, Inc. Delivery and balloon dilatation catheter and method of using
US5599300A (en) 1992-05-11 1997-02-04 Arrow Precision Products, Inc. Method for electrosurgically obtaining access to the biliary tree with an adjustably positionable needle-knife
US5843028A (en) 1992-05-11 1998-12-01 Medical Innovations Corporation Multi-lumen endoscopic catheter
US5397302A (en) 1992-05-11 1995-03-14 Arrow Precision Products, Inc. Method of using a dual lumen biliary catheter
US5536248A (en) 1992-05-11 1996-07-16 Arrow Precision Products, Inc. Method and apparatus for electrosurgically obtaining access to the biliary tree and placing a stent therein
US5342387A (en) 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
DE9213656U1 (en) * 1992-10-09 1992-12-03 Angiomed Ag, 7500 Karlsruhe, De
US5599291A (en) 1993-01-04 1997-02-04 Menlo Care, Inc. Softening expanding ureteral stent
US5630840A (en) 1993-01-19 1997-05-20 Schneider (Usa) Inc Clad composite stent
AU689096B2 (en) 1993-01-27 1998-03-26 Intra Therapeutics, Inc. Vascular and coronary stents
DE69433774T2 (en) 1993-02-19 2005-04-14 Boston Scientific Corp., Natick SURGICAL EXTRACTOR
WO1994021196A2 (en) 1993-03-18 1994-09-29 C.R. Bard, Inc. Endovascular stents
US5401257A (en) * 1993-04-27 1995-03-28 Boston Scientific Corporation Ureteral stents, drainage tubes and the like
US5746745A (en) 1993-08-23 1998-05-05 Boston Scientific Corporation Balloon catheter
US5427115A (en) 1993-09-13 1995-06-27 Boston Scientific Corporation Apparatus for stricture diagnosis and treatment
US6323184B1 (en) 1993-10-15 2001-11-27 Thomas Jefferson University Arteriovenous and venous graft treatments: methods and compositions
US6133242A (en) 1993-10-15 2000-10-17 Thomas Jefferson Univerisity Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
US5535756A (en) 1994-01-06 1996-07-16 Parasher; Vinod K. Catheter with simultaneous brush cytology and scrape biopsy capability
FR2714815B1 (en) 1994-01-10 1996-03-08 Microfil Ind Sa Elastic prosthesis to widen a duct, in particular a blood vessel.
US5486191A (en) 1994-02-02 1996-01-23 John Hopkins University Winged biliary stent
US5556413A (en) 1994-03-11 1996-09-17 Advanced Cardiovascular Systems, Inc. Coiled stent with locking ends
US5547469A (en) 1994-05-13 1996-08-20 Boston Scientific Corporation Apparatus for performing diagnostic and therapeutic modalities in the biliary tree
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US5786344A (en) 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5545210A (en) 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5914345A (en) 1994-10-11 1999-06-22 Endoluminal Therapeutics, Inc. Treatment of tissues to reduce subsequent response to injury
EP0785774B1 (en) 1994-10-12 2001-01-31 Focal, Inc. Targeted delivery via biodegradable polymers
US5765682A (en) 1994-10-13 1998-06-16 Menlo Care, Inc. Restrictive package for expandable or shape memory medical devices and method of preventing premature change of same
US6309411B1 (en) 1994-10-19 2001-10-30 Medtronic Ave, Inc. Method and apparatus to prevent stent migration
US5817152A (en) 1994-10-19 1998-10-06 Birdsall; Matthew Connected stent apparatus
CA2203122A1 (en) 1994-10-20 1996-05-02 Mordechay Beyar Cystoscope delivery system
US5658296A (en) 1994-11-21 1997-08-19 Boston Scientific Corporation Method for making surgical retrieval baskets
US5613980A (en) 1994-12-22 1997-03-25 Chauhan; Tusharsindhu C. Bifurcated catheter system and method
CA2212084C (en) 1995-02-02 2008-11-18 Boston Scientific Corporation Surgical wire basket extractor
US6743198B1 (en) * 1995-03-20 2004-06-01 Conticare Medical, Inc. Self-cleansing bladder drainage device
US5681274A (en) 1995-03-31 1997-10-28 Boston Scientific Corporation Variable length uretheral stent
US5593442A (en) 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5700269A (en) 1995-06-06 1997-12-23 Corvita Corporation Endoluminal prosthesis deployment device for use with prostheses of variable length and having retraction ability
JPH11503056A (en) 1995-06-06 1999-03-23 コルヴィタ コーポレーション Intravascular measurement device and introduction / placement means
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5749918A (en) 1995-07-20 1998-05-12 Endotex Interventional Systems, Inc. Intraluminal graft and method for inserting the same
US5713907A (en) 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
US5769882A (en) 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
DK171865B1 (en) 1995-09-11 1997-07-21 Cook William Europ Expandable endovascular stent
US6193745B1 (en) 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US5824037A (en) 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US5603694A (en) 1995-10-17 1997-02-18 Brown; Joe E. Infusion coil apparatus and method for delivering fluid-based agents intravascularly
US6991614B2 (en) 1995-11-07 2006-01-31 Boston Scientific Scimed, Inc. Ureteral stent for improved patient comfort
US5749921A (en) 1996-02-20 1998-05-12 Medtronic, Inc. Apparatus and methods for compression of endoluminal prostheses
US5885258A (en) * 1996-02-23 1999-03-23 Memory Medical Systems, Inc. Medical instrument with slotted memory metal tube
US6124007A (en) 1996-03-06 2000-09-26 Scimed Life Systems Inc Laminate catheter balloons with additive burst strength and methods for preparation of same
AR001162A1 (en) 1996-03-06 1997-09-24 Parodi Juan C Non-migratory positioning endovascular expander
DE69725120T2 (en) 1996-03-07 2004-07-08 Med Institute, Inc., West Lafayette SPREADABLE STENT
US5665103A (en) 1996-03-07 1997-09-09 Scimed Life Systems, Inc. Stent locating device
CA2199890C (en) 1996-03-26 2002-02-05 Leonard Pinchuk Stents and stent-grafts having enhanced hoop strength and methods of making the same
WO1997038631A1 (en) * 1996-04-18 1997-10-23 Applied Medical Resources Corporation Remote clot management
US5788710A (en) 1996-04-30 1998-08-04 Boston Scientific Corporation Calculus removal
US5647843A (en) 1996-05-24 1997-07-15 Vance Products Incorporated Anti-reflux ureteral stent
US5733326A (en) 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US6027528A (en) 1996-05-28 2000-02-22 Cordis Corporation Composite material endoprosthesis
US5814006A (en) * 1996-05-28 1998-09-29 Planz; Konrad Temporary stent in the urine path
JPH1057496A (en) 1996-06-14 1998-03-03 Olympus Optical Co Ltd Indwelling tube for medical use
US5797952A (en) 1996-06-21 1998-08-25 Localmed, Inc. System and method for delivering helical stents
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5830217A (en) 1996-08-09 1998-11-03 Thomas J. Fogarty Soluble fixation device and method for stent delivery catheters
US5968068A (en) 1996-09-12 1999-10-19 Baxter International Inc. Endovascular delivery system
US5824045A (en) 1996-10-21 1998-10-20 Inflow Dynamics Inc. Vascular and endoluminal stents
US5776142A (en) 1996-12-19 1998-07-07 Medtronic, Inc. Controllable stent delivery system and method
US5776162A (en) * 1997-01-03 1998-07-07 Nitinol Medical Technologies, Inc. Vessel implantable shape memory appliance with superelastic hinged joint
AU728005B2 (en) 1997-02-24 2001-01-04 Cook Urological Inc. Medical device including tipless basket
US6395021B1 (en) 1997-02-26 2002-05-28 Applied Medical Resources Corporation Ureteral stent system apparatus and method
US5795319A (en) 1997-03-07 1998-08-18 Circon Corporation Easily removable ureteral stent
US5911732A (en) 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
US5810838A (en) 1997-03-13 1998-09-22 Solar; Ronald J. Hydraulic method and apparatus for uniform radial compression and catheter mounting of radially expandable intraluminal stents and stented grafts
US5971992A (en) 1997-03-13 1999-10-26 Solar; Ronald J. Hydraulic method and apparatus for uniform radial compression and catheter mounting of radially expandable intraluminal stents and stented grafts
US6059812A (en) * 1997-03-21 2000-05-09 Schneider (Usa) Inc. Self-expanding medical device for centering radioactive treatment sources in body vessels
US6042553A (en) 1997-04-15 2000-03-28 Symbiosis Corporation Linear elastic member
US5868783A (en) * 1997-04-16 1999-02-09 Numed, Inc. Intravascular stent with limited axial shrinkage
WO1998051238A1 (en) * 1997-05-14 1998-11-19 Novo Rps Ulc Expandable stent and method for production of same
US6200307B1 (en) 1997-05-22 2001-03-13 Illumenex Corporation Treatment of in-stent restenosis using cytotoxic radiation
DE19722857A1 (en) * 1997-05-23 1998-11-26 Biotronik Mess & Therapieg Stent
US6004328A (en) 1997-06-19 1999-12-21 Solar; Ronald J. Radially expandable intraluminal stent and delivery catheter therefore and method of using the same
US6306426B1 (en) 1997-08-11 2001-10-23 Allergan Sales, Inc. Implant device with a retinoid for improved biocompatibility
US6306166B1 (en) 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
US5921952A (en) 1997-08-14 1999-07-13 Boston Scientific Corporation Drainage catheter delivery system
US6248100B1 (en) 1997-08-14 2001-06-19 Scimed Life Systems, Inc. Drainage catheter delivery system
US6254608B1 (en) 1997-08-22 2001-07-03 Ronald J. Solar Sheathless delivery catheter for radially expandable intraluminal stents and stented grafts
US5897533A (en) 1997-09-02 1999-04-27 Delcath Systems, Inc. Catheter flow and lateral movement controller
US6066149A (en) * 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US6099534A (en) 1997-10-01 2000-08-08 Scimed Life Systems, Inc. Releasable basket
US6183482B1 (en) 1997-10-01 2001-02-06 Scimed Life Systems, Inc. Medical retrieval basket with legs shaped to enhance capture and reduce trauma
JP2001518328A (en) * 1997-10-01 2001-10-16 ボストン サイエンティフィック リミテッド Expansion system and related methods
US5961536A (en) 1997-10-14 1999-10-05 Scimed Life Systems, Inc. Catheter having a variable length balloon and method of using the same
US5908435A (en) 1997-10-23 1999-06-01 Samuels; Shaun L. W. Expandable lumen device and method of use
US6120534A (en) * 1997-10-29 2000-09-19 Ruiz; Carlos E. Endoluminal prosthesis having adjustable constriction
JP2002508209A (en) 1997-12-15 2002-03-19 プロリフィックス メディカル, インコーポレイテッド Vascular stent for reduction of restenosis
EP1043949A2 (en) 1997-12-31 2000-10-18 Pharmasonics, Inc. Methods and systems for the inhibition of vascular hyperplasia
US5873907A (en) 1998-01-27 1999-02-23 Endotex Interventional Systems, Inc. Electrolytic stent delivery system and methods of use
US6290718B1 (en) 1998-02-02 2001-09-18 Regeneration Technologies, Inc. Luminal graft, stent or conduit made of cortical bone
US5938585A (en) 1998-03-20 1999-08-17 Boston Scientific Corporation Anchoring and positioning device and method for an endoscope
US6319261B1 (en) 1998-03-20 2001-11-20 The Trustees Of Columbia University In The City Of New York Electrohydraulic lithotripsy basket
AU746955B2 (en) 1998-03-27 2002-05-09 Cook Urological Inc. Minimally-invasive medical retrieval device
JP2002512072A (en) * 1998-04-23 2002-04-23 サイムド ライフ システムズ, インコーポレイテッド Medical collection device with loop basket
US5944728A (en) 1998-04-23 1999-08-31 Boston Scientific Corporation Surgical retrieval basket with the ability to capture and release material
US6295940B1 (en) 1998-06-22 2001-10-02 Sew-Fine, Llc System and method for processing workpieces
US6156064A (en) 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
US6117104A (en) 1998-09-08 2000-09-12 Advanced Cardiovascular Systems, Inc. Stent deployment system and method of use
US6019779A (en) 1998-10-09 2000-02-01 Intratherapeutics Inc. Multi-filar coil medical stent
US6258118B1 (en) * 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
US6159220A (en) 1999-03-11 2000-12-12 Scimed Life Systems, Inc. Medical retrieval device
US6214037B1 (en) * 1999-03-18 2001-04-10 Fossa Industries, Llc Radially expanding stent
US6709465B2 (en) 1999-03-18 2004-03-23 Fossa Medical, Inc. Radially expanding ureteral device
US7214229B2 (en) 1999-03-18 2007-05-08 Fossa Medical, Inc. Radially expanding stents
US6325825B1 (en) * 1999-04-08 2001-12-04 Cordis Corporation Stent with variable wall thickness
US6241719B1 (en) 1999-05-13 2001-06-05 Micro Therapeutics, Inc. Method for forming a radioactive stent
US6146404A (en) 1999-09-03 2000-11-14 Scimed Life Systems, Inc. Removable thrombus filter
US6221042B1 (en) 1999-09-17 2001-04-24 Scimed Life Systems, Inc. Balloon with reversed cones
US6312463B1 (en) * 2000-02-01 2001-11-06 Endotex Interventional Systems, Inc. Micro-porous mesh stent with hybrid structure
US6264664B1 (en) 2000-03-10 2001-07-24 General Science And Technology Corp. Surgical basket devices
US6953476B1 (en) 2000-03-27 2005-10-11 Neovasc Medical Ltd. Device and method for treating ischemic heart disease
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
US20030135268A1 (en) 2000-04-11 2003-07-17 Ashvin Desai Secure stent for maintaining a lumenal opening
GB0012764D0 (en) 2000-05-26 2000-07-19 Tayside University Hospitals N G-stent
US6524268B2 (en) 2001-06-12 2003-02-25 George M. Hayner Combination ureteral infusion catheter/drainage stent
JP4294470B2 (en) 2001-06-14 2009-07-15 クック インコーポレイテッド Intravascular filter
US6908447B2 (en) 2002-04-18 2005-06-21 Scimed Life Systems, Inc. Anti-reflux ureteral stents and methods
US7485150B2 (en) 2002-04-23 2009-02-03 Boston Scientific Scimed, Inc. Drainage devices and methods
US7357818B2 (en) 2003-03-26 2008-04-15 Boston Scientific Scimed, Inc. Self-retaining stent
US6929664B2 (en) 2003-12-05 2005-08-16 Fossa Medical, Inc. Open lumen stents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973301A (en) * 1989-07-11 1990-11-27 Israel Nissenkorn Catheter and method of using same
US5129910A (en) * 1991-07-26 1992-07-14 The Regents Of The University Of California Stone expulsion stent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007037797A (en) * 2005-08-03 2007-02-15 Vector Kk Stent for ureter

Also Published As

Publication number Publication date
US20050060023A1 (en) 2005-03-17
CA2431652A1 (en) 2002-07-11
US6709465B2 (en) 2004-03-23
EP1347716B1 (en) 2008-04-30
DE60133834T2 (en) 2008-12-24
DE60133834D1 (en) 2008-06-12
US20010021835A1 (en) 2001-09-13
CA2431652C (en) 2010-03-23
ATE393605T1 (en) 2008-05-15
US7674283B2 (en) 2010-03-09
US20020183853A1 (en) 2002-12-05
EP1347716A1 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
US6709465B2 (en) Radially expanding ureteral device
US6214037B1 (en) Radially expanding stent
US7214229B2 (en) Radially expanding stents
JP4183386B2 (en) Medical device having one or more helical coils
EP3157465B1 (en) Biliary stent
EP1294308B1 (en) Selectively expandable and releasable stent
US20110054381A1 (en) Biliary shunts, delivery systems, and methods of using the same
JP2013208468A (en) Method and apparatus for deploying short length ureteral stent
EP1861156A1 (en) Access catheter having dilation capability
US20160317167A1 (en) Filter apparatuses and methods of using same
US20210267780A1 (en) Solid Wire Ureteral Stent
US10368974B2 (en) Gallbladder implants and systems and methods for the delivery thereof
CN109224260B (en) Bidirectional displacement-preventing biliary tract internal drainage tube and implanting device
JPH0475665A (en) Extension tool for endoscope

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2431652

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001961878

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001961878

Country of ref document: EP